discover

Biogen And Neomorph Announce Multi-Target Research Collaboration To Discover And Develop Molecular Glue Degraders For Alzheimer’S, Rare, And Immunological Diseases

Biogen And Neomorph Announce Multi-Target Research Collaboration To Discover And Develop Molecular Glue Degraders For Alzheimer’S, Rare, And Immunological...

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications

BeyondSpring, Inc.SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by EisaiThe SEED-Eisai Research Collaboration leverages...